Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
influenza vaccine, recombinant hemagglutinin (1 trial)
d-ribose (1 trial)
Influenza, Human (Phase 3)
Trials (2 total)
Trial APIs (2 total)